Page 115 - GPD-3-3

Gene & Protein in Disease Exploring serum inflammatory biomarkers in GBM

30. Candia J, Daya GN, Tanaka T, Ferrucci L, Walker KA. alteration of prostaglandin E2 levels in patients with brain
Assessment of variability in the plasma 7k SomaScan tumors before and after tumor removal. J Neurooncol.
proteomics assay. Sci Rep. 2022;12(1):17147.
2002;57(2):147-150.
doi: 10.1038/s41598-022-22116-0
doi: 10.1023/a:1015782809966
31. Petrik V, Saadoun S, Loosemore A, et al. Serum alpha 2-HS 41. Lombardi F, Augello FR, Artone S, et al. Up-regulation of
glycoprotein predicts survival in patients with glioblastoma. cyclooxygenase-2 (COX-2) expression by temozolomide
Clin Chem. 2008;54(4):713-722. (TMZ) in human glioblastoma (GBM) cell lines. Int J Mol
doi: 10.1373/clinchem.2007.096792 Sci. 2022;23(3):1545.
32. Topkan E, Besen AA, Mertsoylu H, Kucuk A, Pehlivan B, doi: 10.3390/ijms23031545
Selek U. Prognostic value of C-reactive protein to albumin 42. Kim JD, Ahn BM, Joo BS, Kwon JY, Chung HJ, Yu SB.
ratio in glioblastoma multiforme patients treated with Effect of propofol on prostaglandin E2 production and
concurrent radiotherapy and temozolomide. Int J Inflam. prostaglandin synthase-2 and cyclooxygenase-2 expressions
2020;2020:6947382. in amniotic membrane cells. J Anesth. 2014;28(6):911-918.
doi: 10.1155/2020/6947382 doi: 10.1007/s00540-014-1830-x
33. He ZQ, Duan H, Ke C, et al. Evaluation of cumulative 43. Dean PT, Hooks SB. Pleiotropic effects of the COX-2/PGE2
prognostic score based on pretreatment plasma fibrinogen axis in the glioblastoma tumor microenvironment. Front
and serum albumin levels in patients with newly diagnosed Oncol. 2022;12:1116014.
high-grade gliomas. Oncotarget. 2017;8(30):49605-49614.
doi: 10.3389/fonc.2022.1116014
doi: 10.18632/oncotarget.17849
44. Sproull M, Mathen P, Miller CA, et al. A serum proteomic
34. Borg N, Guilfoyle MR, Greenberg DC, Watts C, Thomson S. signature predicting survival in patients with glioblastoma.
Serum albumin and survival in glioblastoma multiforme. J Biochem Anal Stud. 2020;4(1).
J Neurooncol. 2011;105(1):77-81.
doi: 10.16966/2576-5833.117
doi: 10.1007/s11060-011-0562-0
45. Nijaguna MB, Schröder C, Patil V, et al. Definition of a
35. Wójtowicz K, Czarzasta K, Przepiorka L, et al. Brain- serum marker panel for glioblastoma discrimination and
derived neurotrophic factor (BDNF) concentration levels in identification of Interleukin 1β in the microglial secretome
cerebrospinal fluid and plasma in patients with glioblastoma: as a novel mediator of endothelial cell survival induced by
A prospective, observational, controlled study. Cureus. C-reactive protein. J Proteomics. 2015;128:251-261.
2023;15(11):e48237.
doi: 10.1016/j.jprot.2015.07.026
doi: 10.7759/cureus.48237
46. Wach J, Apallas S, Schneider M, et al. Baseline serum
36. Ilhan-Mutlu A, Wagner L, Widhalm G, et al. Exploratory C-reactive protein and plasma fibrinogen-based score in
investigation of eight circulating plasma markers in brain the prediction of survival in glioblastoma. Front Oncol.
tumor patients. Neurosurg Rev. 2013;36(1):45-55; discussion 2021;11:653614.
55-56.
doi: 10.3389/fonc.2021.653614
doi: 10.1007/s10143-012-0401-6
47. Gállego Pérez-Larraya J, Paris S, Idbaih A, et al. Diagnostic
37. Warrier NM, Agarwal P, Kumar P. Integrative analysis and prognostic value of preoperative combined GFAP,
to identify genes associated with stemness and immune IGFBP-2, and YKL-40 plasma levels in patients with
infiltration in glioblastoma. Cells. 2021;10(10):2765. glioblastoma. Cancer. 2014;120(24):3972-3980.
doi: 10.3390/cells10102765 doi: 10.1002/cncr.28949
38. Kluckova K, Kozak J, Svajdler M, et al. BDNF, sHLA-G, 48. Baumgarten P, Quick-Weller J, Gessler F, et al. Pre- and
and sTREM-1 are useful blood biomarkers for identifying early postoperative GFAP serum levels in glioma and brain
grade IV glioma patients. Neoplasma. 2023;70(1):166-176. metastases. J Neurooncol. 2018;139(3):541-546.
doi: 10.4149/neo_2023_221129N1147 doi: 10.1007/s11060-018-2898-1
39. Zhou M, Wiemels JL, Bracci PM, et al. Circulating levels 49. Vietheer JM, Rieger J, Wagner M, Senft C, Tichy J, Foerch C.
of the innate and humoral immune regulators CD14 Serum concentrations of glial fibrillary acidic protein
and CD23 are associated with adult glioma. Cancer Res. (GFAP) do not indicate tumor recurrence in patients with
2010;70(19):7534-7542. glioblastoma. J Neurooncol. 2017;135(1):193-199.
doi: 10.1158/0008-5472.Can-10-0815 doi: 10.1007/s11060-017-2565-y
40. Loh JK, Hwang SL, Lieu AS, Huang TY, Howng SL. The 50. Wastowski IJ, Simões RT, Yaghi L, et al. Human leukocyte

Volume 3 Issue 3 (2024) 15 doi: 10.36922/gpd.3580